Form 8-K - Current report:
SEC Accession No. 0001445305-13-001111
Filing Date
2013-05-03
Accepted
2013-05-03 17:06:32
Documents
2
Period of Report
2013-05-03
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K a03312013-8kearningsrelease.htm 8-K 182068
2 cumberlandpharmaceuti_image1.jpg GRAPHIC 37721
  Complete submission text file 0001445305-13-001111.txt   235234
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 13813578
SIC: 2834 Pharmaceutical Preparations